STAVANGER, Norway, May 10, 2016 -- The following primary insiders have on 9 May 2016 acquired shares in Statoil ASA (OSE:STL, NYSE:STO) at a share price of NOK 136.38 in connection with the company's long-term incentive programme.
The long-term incentive programme is a fixed, monetary compensation calculated as a portion of the participant's base salary; ranging from 20 - 30 per cent depending on the individual's position. On behalf of the participant, the company acquires shares equivalent to the net annual amount. The grant is subject to a three year lock-in period.
Number of acquired shares and their new total shareholding is listed in the table below. The trade has been made through DNB Markets.
| Name |
New total Statoil share holding |
LTI allocation 2016 |
| Bacher Lars Christian | 23 896 | 1470 |
| Dodson Timothy* | 31 458 | 1544 |
| Gjærum Reidar | 26 772 | 890 |
| Hegge, Hans Jakob | 26 063 | 1743 |
| Hovden Magne Andre | 14 021 | 848 |
| Klouman Hans Henrik | 28 090 | 1577 |
| Knight John Nicholas | 100 501 | 12936 |
| Mathieu Philippe François | 10 771 | 674 |
| Nylund, Arne Sigve | 10 863 | 1602 |
| Opedal Anders | 16 085 | 1329 |
| Reitan, Torgrim | 31 053 | 1618 |
| Rummelhoff, Irene | 19 719 | 1724 |
| Skeie Svein | 23 308 | 743 |
| Sætre Eldar | 44 852 | 4149 |
| Økland, Jens | 13 383 | 1997 |
| Øvrum Margareth | 46 249 | 1601 |
* In addition, the following primary insider in Statoil ASA has sold shares in Statoil ASA:
Tim Dodson, Executive Vice President in Statoil ASA has on 9 May 2016 sold 4,000 shares in Statoil ASA at a price of NOK 133.6 per share and will after the sale hold 27,458 shares in Statoil ASA (including the shares allocated through the LTI scheme).
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)
HUG#2011018
CONTACT: Peter Hutton, SVP Investor Relations,
mbl: +44 7881 918 792
Morten Sven Johannessen, VP Investor Relations USA,
mbl +1 203 570 2524


Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Italy Fines Apple €98.6 Million Over App Store Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 



